Ownership history in Mariner, LLC · 11 quarters on record
This page tracks every 13F SEC filing in which Mariner, LLC reported a position in IOVANCE BIOTHERAPEUTICS INC (IOVA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 22,291 | +6,369 | +40.0% | 0.00% | $48K | $2.17 |
| 2025 Q1 | REDUCED | 15,922 | -111 | -0.7% | 0.00% | $53K | $3.33 |
| 2024 Q4 | REDUCED | 16,033 | -2,483 | -13.4% | 0.00% | $119K | $7.40 |
| 2024 Q3 | REDUCED | 18,516 | -866 | -4.5% | 0.00% | $174K | $9.39 |
| 2024 Q2 | ADDED | 19,382 | +2,722 | +16.3% | 0.00% | $155K | $8.02 |
| 2024 Q1 | ADDED | 16,660 | +287 | +1.8% | 0.00% | $247K | $14.82 |
| 2023 Q4 | REDUCED | 16,373 | -355,477 | -95.6% | 0.00% | $133K | $8.13 |
| 2023 Q3 | ADDED | 371,850 | +192,450 | +107.3% | 0.00% | $1.7M | $4.55 |
| 2023 Q2 | ADDED | 179,400 | +72,100 | +67.2% | 0.00% | $1.3M | $7.04 |
| 2023 Q1 | ADDED | 107,300 | +44,600 | +71.1% | 0.00% | $656K | $6.11 |
As of 2025 Q4 — sorted by position size